Literature DB >> 18279433

Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study.

H Bolay1, Y A Bayazit, B Gündüz, A K Ugur, D Akçali, S Altunyay, S Ilica, A Babacan.   

Abstract

Otoacoustic emission (OAE) testing enables us to identify the cochlear component of a hearing disorder and to monitor objectively minute changes in cochlear status undetectable by other audiological methods. Contralateral sound-induced suppression is mediated by medial superior olivary complex efferents which induce hyperpolarization counteracting the amplifying effects of outer hair cell (OHC) activity. The aim of this study was to assess functions of cochlea and its efferents in migraine using OAE testing and contralateral suppression of transiently evoked OAEs (TEOAE). Fifty-three migraineurs (106 ears) and 41 healthy subjects (82 ears) were included and pure tone audiometry (PTA), speech discrimination scores (SDS), distortion product OAE (DPOAE), TEOAE and contralateral suppression of TEOAEs were tested. PTA and SDS of migraineurs and controls were not different (P > 0.05). DPOAEs were tested between 1 and 6 kHz and a significant difference was detected only at 5 kHz frequency, where DPOAE amplitudes in migraine with aura (MA) were lower than in controls (P < 0.03). The mean amplitudes of TEOAEs were statistically insignificant between controls and migraine groups. Contralateral sound stimulus induced significant decrease in amplitudes of TEOAE (P = 0.005) in controls. In patients with migraine without aura and MA, mean amplitudes of TEOAEs were not suppressed by contralateral sound stimulus (P > 0.05). As PTA, SDS and DPOAE tests demonstrate normal functioning of inner ear between 1 and 4 kHz, absence of suppression of the TEOAEs by contralateral sound stimulation indicates the presence of dysfunction either in the medial olivocochlear complex in the brainstem or at the synaptic transmission between olivocochlear efferents and OHCs in the cochlea. Disruption in the contralateral suppression may be one of the mechanisms predisposing to the phonophobia symptom associated with migraine headache.

Entities:  

Mesh:

Year:  2008        PMID: 18279433     DOI: 10.1111/j.1468-2982.2008.01534.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

1.  Assessment of otoacoustic emission suppression in women with migraine and phonophobia.

Authors:  Lucia Joffily; Marco Antônio de Melo Tavares de Lima; Maurice Borges Vincent; Silvana Maria Monte Coelho Frota
Journal:  Neurol Sci       Date:  2016-03-31       Impact factor: 3.307

Review 2.  Migraine and Cochlear Symptoms.

Authors:  Xin Ma; Yu-Jie Ke; Yuan-Yuan Jing; Tong-Xiang Diao; Li-Sheng Yu
Journal:  Curr Med Sci       Date:  2021-08-17

3.  Comparison of Auditory Brain Stem Responses and Otoacoustic Emission of Autism with Healthy Children.

Authors:  Seyed Gholamreza Noorazar; Yalda Jabbari Moghaddam; Rasul Kharzaee; Mojtaba Sohrabpour
Journal:  Galen Med J       Date:  2020-12-22

Review 4.  Migraine is associated with altered processing of sensory stimuli.

Authors:  Andrea M Harriott; Todd J Schwedt
Journal:  Curr Pain Headache Rep       Date:  2014-11

5.  A study of cochlear and auditory pathways in patients with tension-type headache.

Authors:  Hang Shen; Wenyang Hao; Libo Li; Daofeng Ni; Liying Cui; Yingying Shang
Journal:  J Headache Pain       Date:  2015-08-13       Impact factor: 7.277

Review 6.  Pathophysiology and Therapy of Associated Features of Migraine.

Authors:  Maria Dolores Villar-Martinez; Peter J Goadsby
Journal:  Cells       Date:  2022-09-05       Impact factor: 7.666

Review 7.  Cortical inhibition and habituation to evoked potentials: relevance for pathophysiology of migraine.

Authors:  Filippo Brighina; Antonio Palermo; Brigida Fierro
Journal:  J Headache Pain       Date:  2009-02-10       Impact factor: 7.277

8.  Effects of gestational and lactational exposure to low dose mercury chloride (HgCl2) on behaviour, learning and hearing thresholds in WAG/Rij rats.

Authors:  Deniz Sahin; Cem Onur Erdolu; Sabriye Karadenizli; Ahmet Kara; Gunce Bayrak; Sumeyye Beyaz; Buse Demir; Nurbay Ates
Journal:  EXCLI J       Date:  2016-06-21       Impact factor: 4.068

9.  Risk of Vestibulocochlear Disorders in Patients with Migraine or Non-Migraine Headache.

Authors:  Sang-Hwa Lee; Jong-Ho Kim; Young-Suk Kwon; Jae-June Lee; Jong-Hee Sohn
Journal:  J Pers Med       Date:  2021-12-08

10.  Prophylactic treatment of vestibular migraine.

Authors:  Márcio Cavalcante Salmito; Juliana Antoniolli Duarte; Lígia Oliveira Golçalves Morganti; Priscila Valéria Caus Brandão; Bruno Higa Nakao; Thais Rodrigues Villa; Fernando Freitas Ganança
Journal:  Braz J Otorhinolaryngol       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.